Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581529 · ClinicalTrials.gov registry record · Phase 2
Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy
A Phase 2 study, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT00581529 is a Phase 2 study that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 34 participants.
The verdict
NCT00581529, a Phase 2 study, was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a phase I- II feasibility study for delivering partial breast irradiation (PBI) in selected patients with early stage, lymph node negative, breast cancer after breast-conserving surgery using accelerated Intensity Modulated Radiotherapy (IMRT).
Interventions
- RADIATION IMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2004-11 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581529
The ClinicalTrials.gov registry entry for NCT00581529 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMRT is the first listed.
NCT00581529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581529 about?
NCT00581529 is a clinical study titled "Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy". This is a phase I- II feasibility study for delivering partial breast irradiation (PBI) in selected patients with early stage, lymph node negative, breast cancer after breast-conserving surgery using accelerated Intensity Modulated Radiotherapy (IMRT).
What is the current status of trial NCT00581529?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2004-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00581529?
The interventions under investigation include: IMRT (RADIATION).
Who is sponsoring clinical trial NCT00581529?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.